Aquestive Therapeutics, Inc. Variable Lease, Cost
Aquestive Therapeutics, Inc. (AQST) reported Variable Lease, Cost of $140.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-11
- Aquestive Therapeutics, Inc. variable lease, cost for the quarter ending 2026-06-30 was $140.00K, a 12.90% increase year-over-year.
- Aquestive Therapeutics, Inc. variable lease, cost for the quarter ending 2026-03-31 was $114.00K, a 22.58% increase year-over-year.
- Aquestive Therapeutics, Inc. variable lease, cost for the quarter ending 2025-12-31 was $114.00K, a 17.39% decline year-over-year.
- Aquestive Therapeutics, Inc. variable lease, cost for the quarter ending 2025-09-30 was $118.00K, a 4.07% decline year-over-year.
- Aquestive Therapeutics, Inc. variable lease, cost for fiscal 2025 was $449.00K, a 7.80% decline from fiscal 2024.
- Aquestive Therapeutics, Inc. variable lease, cost for fiscal 2024 was $487.00K, a 8.95% increase from fiscal 2023.
- Aquestive Therapeutics, Inc. variable lease, cost for fiscal 2023 was $447.00K, a 0.45% decline from fiscal 2022.
- Aquestive Therapeutics, Inc. variable lease, cost for fiscal 2022 was $449.00K, a 4.26% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 3 month as first filed | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 9 month as first filed | Variable Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140.00K 10-Q · filed 2026-08-11 | $254.00K 10-Q · filed 2026-08-11 | $368.00K derived: sum of 3 quarters · filed 2026-08-11 | $486.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | $114.00K 10-Q · filed 2026-05-13 | $228.00K derived: sum of 2 quarters · filed 2026-05-13 | $346.00K derived: sum of 3 quarters · filed 2026-05-13 | $470.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $232.00K derived: sum of 2 quarters · filed 2026-03-04 | $356.00K derived: sum of 3 quarters · filed 2026-08-11 | $449.00K 10-K · filed 2026-03-04 | ||
| 2025-09-30 | $118.00K 10-Q · filed 2025-11-05 | $242.00K derived: sum of 2 quarters · filed 2026-08-11 | $335.00K 10-Q · filed 2025-11-05 | $473.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | $124.00K 10-Q · filed 2026-08-11 | $217.00K 10-Q · filed 2026-08-11 | $355.00K derived: sum of 3 quarters · filed 2026-08-11 | $478.00K derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $93.00K 10-Q · filed 2026-05-13 | $231.00K derived: sum of 2 quarters · filed 2026-05-13 | $354.00K derived: sum of 3 quarters · filed 2026-05-13 | $465.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | $138.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $261.00K derived: sum of 2 quarters · filed 2026-03-04 | $372.00K derived: sum of 3 quarters · filed 2026-03-04 | $487.00K 10-K · filed 2026-03-04 | ||
| 2024-09-30 | $123.00K 10-Q · filed 2025-11-05 | $234.00K derived: sum of 2 quarters · filed 2025-11-05 | $349.00K 10-Q · filed 2025-11-05 | $458.00K derived: sum of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | $111.00K 10-Q · filed 2025-08-11 | $226.00K 10-Q · filed 2025-08-11 | $335.00K derived: sum of 3 quarters · filed 2025-08-11 | $444.00K derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2024-03-31 | $115.00K 10-Q · filed 2025-05-12 | $224.00K derived: sum of 2 quarters · filed 2025-05-12 | $333.00K derived: sum of 3 quarters · filed 2025-05-12 | $454.00K derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $218.00K derived: sum of 2 quarters · filed 2025-03-05 | $339.00K derived: sum of 3 quarters · filed 2025-03-05 | $447.00K 10-K · filed 2025-03-05 | ||
| 2023-09-30 | $109.00K 10-Q · filed 2024-11-04 | $230.00K derived: sum of 2 quarters · filed 2024-11-04 | $338.00K 10-Q · filed 2024-11-04 | $454.00K derived: sum of 4 quarters · filed 2024-11-04 | ||
| 2023-06-30 | $121.00K 10-Q · filed 2024-08-06 | $229.00K 10-Q · filed 2024-08-06 | $345.00K derived: sum of 3 quarters · filed 2024-08-06 | $455.00K derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $108.00K 10-Q · filed 2024-05-07 | $224.00K derived: sum of 2 quarters · filed 2024-05-07 | $334.00K derived: sum of 3 quarters · filed 2024-05-07 | $461.00K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $116.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $226.00K derived: sum of 2 quarters · filed 2024-03-05 | $353.00K derived: sum of 3 quarters · filed 2024-03-05 | $449.00K 10-K · filed 2024-03-05 | ||
| 2022-09-30 | $110.00K 10-Q · filed 2023-11-06 | $237.00K derived: sum of 2 quarters · filed 2023-11-06 | $333.00K 10-Q · filed 2023-11-06 | $450.00K derived: sum of 4 quarters · filed 2023-11-06 | ||
| 2022-06-30 | $127.00K 10-Q · filed 2023-08-07 | $223.00K 10-Q · filed 2023-08-07 | $340.00K derived: sum of 3 quarters · filed 2023-08-07 | $457.00K derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $96.00K 10-Q · filed 2023-05-02 | $213.00K derived: sum of 2 quarters · filed 2023-05-02 | $330.00K derived: sum of 3 quarters · filed 2023-05-02 | $446.00K derived: sum of 4 quarters · filed 2023-05-02 | ||
| 2021-12-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $234.00K derived: sum of 2 quarters · filed 2023-03-31 | $350.00K derived: sum of 3 quarters · filed 2023-03-31 | $469.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $117.00K 10-Q · filed 2022-11-01 | $233.00K derived: sum of 2 quarters · filed 2022-11-01 | $352.00K 10-Q · filed 2022-11-01 | $565.00K derived: sum of 4 quarters · filed 2022-11-01 | ||
| 2021-06-30 | $116.00K 10-Q · filed 2022-08-02 | $235.00K 10-Q · filed 2022-08-02 | $448.00K derived: sum of 3 quarters · filed 2022-08-02 | $508.00K derived: sum of 4 quarters · filed 2022-08-02 | ||
| 2021-03-31 | $119.00K 10-Q · filed 2022-05-04 | $332.00K derived: sum of 2 quarters · filed 2022-05-04 | $392.00K derived: sum of 3 quarters · filed 2022-05-04 | $452.00K derived: sum of 4 quarters · filed 2022-05-04 | ||
| 2020-12-31 | $213.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $273.00K derived: sum of 2 quarters · filed 2022-03-08 | $333.00K derived: sum of 3 quarters · filed 2022-03-08 | $379.00K 10-K · filed 2022-03-08 | ||
| 2020-09-30 | $60.00K 10-Q · filed 2021-11-02 | $89.00K 10-Q · filed 2020-11-04 | $120.00K derived: sum of 2 quarters · filed 2021-11-02 | $166.00K 10-Q · filed 2021-11-02 | $255.00K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $60.00K 10-Q · filed 2021-08-03 | $166.00K 10-Q · filed 2021-08-03 | ||||
| 2020-03-31 | $106.00K 10-Q · filed 2021-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |